Want to see KR:099190 full AI Analyst Report?
i-SENS, Inc. (099190) AI Stock Analysis
i-SENS, Inc.
(Korea Exchange:099190)
The score is primarily held back by weakened financial performance (swing from profits to losses and inconsistent free cash flow) and a clearly negative technical trend (below key moving averages with negative MACD). Offsetting factors are strong recent revenue growth and a moderately supported balance sheet, while valuation is mixed due to losses (negative P/E) and only a modest dividend yield.
i-SENS, Inc. (099190) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- KRW 471.98B
- Dividend Yield
- 0.57%
- Average Volume (3M)
- 39.07K
- Price to Earnings (P/E)
- -188.2
- Beta (1Y)
- 0.33
- Revenue Growth
- 6.64%
- EPS Growth
- -250.80%
- Country
- KR
- Employees
- ―
- Sector
- General
- Sector Strength
- 55
- Industry
- Medical - Devices
i-SENS, Inc. Business Overview & Revenue Model
Company Description
i-SENS Inc is a South Korean enterprise specializing in the development and marketing of biosensor technology. The company's core product line consists of blood glucose monitoring systems, including a variety of meters, monitors, and comprehensive te...
i-SENS, Inc. Financial Statement Overview
Summary
Revenue growth has accelerated meaningfully, and gross margin has held relatively stable (~39–40%), but profitability has deteriorated into losses in 2024–2025 with negative net margins. Operating cash flow remains positive, yet free cash flow has been volatile and turned negative again in the latest year, increasing execution and funding risk despite a moderately healthy balance sheet.
Income Statement
42NeutralBalance Sheet
64PositiveCash Flow
46Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 314.31B | 315.44B | 291.14B | 265.12B | 264.84B | 232.93B |
| Gross Profit | 124.61B | 125.26B | 113.53B | 106.06B | 105.49B | 102.06B |
| EBITDA | 36.67B | 13.72B | 24.43B | 22.68B | 33.08B | 42.49B |
| Net Income | -5.79B | -5.15B | -1.79B | 3.71B | 16.14B | 25.45B |
Balance Sheet | ||||||
| Total Assets | 591.04B | 577.66B | 590.87B | 498.82B | 449.57B | 429.18B |
| Cash, Cash Equivalents and Short-Term Investments | 99.02B | 98.19B | 119.14B | 51.87B | 72.52B | 100.67B |
| Total Debt | 170.56B | 173.80B | 173.77B | 143.79B | 100.85B | 100.87B |
| Total Liabilities | 234.55B | 239.34B | 247.89B | 195.32B | 144.81B | 144.44B |
| Stockholders Equity | 332.98B | 315.25B | 324.70B | 284.35B | 285.81B | 268.33B |
Cash Flow | ||||||
| Free Cash Flow | -13.91B | -8.34B | 7.38B | -29.60B | -16.61B | -30.97B |
| Operating Cash Flow | 15.96B | 20.12B | 22.96B | 13.05B | 6.65B | 17.22B |
| Investing Cash Flow | -27.93B | -35.72B | -40.30B | -63.78B | 16.50B | -59.57B |
| Financing Cash Flow | 5.79B | -6.49B | 38.78B | 34.94B | -9.22B | 58.25B |
i-SENS, Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:099190, the sentiment is Negative. The current price of 16830.00 is above the 20-day moving average (MA) of 16288.00, above the 50-day MA of 16650.80, and below the 200-day MA of 17930.70, indicating a bearish trend. The MACD of -182.77 indicates Positive momentum. The RSI at 45.63 is Neutral, neither overbought nor oversold. The STOCH value of 28.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:099190.
i-SENS, Inc. Peers Comparison
Overall Rating
- KR:09919049Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| KR:099190 | 49Neutral | KRW 471.98B | -188.24 | ― | 0.57% | 6.64% | -250.80% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| KR:099190 | i-SENS, Inc. | 15960.00 | -634.90 | -3.83% | |
| KR:174900 | AbClon, Inc. | 18470.00 | -4130.00 | -18.27% | |
| KR:372320 | Curocell, Inc. | 23050.00 | -14900.00 | -39.26% | |
| KR:377740 | BioNote, Inc. | 4650.00 | -515.74 | -9.98% | |
| KR:389470 | Inventage Lab, Inc. | 22100.00 | -26950.00 | -54.94% | |
| KR:475960 | TOMOCUBE, Inc. | 30500.00 | -12450.00 | -28.99% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 28, 2026